[Annual update of pulmonary infectious diseases in 2022].

Yang, Q Y; Qu, J M

Yang, Q Y; Qu, J M.

Yang QY; Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine;Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases Shanghai, Shanghai 200025, China.
Qu JM; Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine;Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases Shanghai, Shanghai 200025, China.

Zhonghua Jie He He Hu Xi Za Zhi ; 46(2): 168-171, 2023 Feb 12.

Article in Chinese | MEDLINE | ID: covidwho-2246531

ABSTRACT

ABSTRACT

In 2022, coronavirus disease 2019 (COVID-19) remains rampant across the world. Several remarkable studies concerning pulmonary infectious diseases have been published during this pandemic. This review summarized the representative academic and translational medical progress over the past year (from October 1, 2021, to September 30, 2022), including COVID-19, community/hospital-acquired pneumonia, tuberculosis, and other respiratory viral infections.

Subject(s)

COVID-19; Communicable Diseases; Community-Acquired Infections; Influenza, Human; Pneumonia; Humans; SARS-CoV-2; Lung; Communicable Diseases/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Communicable Diseases / Community-Acquired Infections / Influenza, Human / COVID-19 Type of study: Observational study Limits: Humans Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2023 Document Type: Article Affiliation country: Cma.j.cn112147-20221110-00890

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google